Clinical Trial Update: Transplantation of Autologous Bone Marrow or Leukapheresis-Derived Stem Cells for Treatment of Spinal Cord Injury [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating autologous bone marrow or leukapheresis-derived stem cells for spinal cord injury.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Spinal Cord Injury

Snippet

Sponsor: Stem Cells Arabia | Conditions: Spinal Cord Injury | Phase 2 | Status: UNKNOWN